Investigation of Predictors of Typing Performance in Office Employees With Neck Pain

April 6, 2022 updated by: Arzu Keskin Aktan, Afyonkarahisar Health Sciences University

The Predictors of Typing Performance in Office Employees With Neck Pain; Neck Disability, Muscle Activity, Posture, and Demographics

Determining the predictors that are effective on work performance and preventive approaches to be developed for these predictors must be individual and adaptable to every environment, time, and equipment. In this context, the purpose of the present study was to show the relations between neck disability, Upper Trapezius (UT) muscle activation, posture, and demographic characteristics with typing task performance in office employees who have neck pain by using their equipment in their workplaces.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

The present study was conducted to show the relations between neck disability, UT muscle activation, posture, and demographic characteristics with typing task performance in office employees who have neck pain by using their equipment in their workplaces. We hypothesized that UT muscle activation, working posture, and age might be the main predictors of typing performance in office employees with neck pain. For this purpose, full-time office employees who use computers for at least 3 hours a day and have neck pain were invited to the study. Volunteers without any health concern, upper-body injury, and surgery provided informed, written consent to participate in the study.

The participants were given a 10-minute typing task in their working environments, during which right and left UT muscle activation was recorded with Surface Electromyography (sEMG). Work posture was evaluated with Rapid Upper Limb Assessment (RULA) and Forward Head Posture (FHP) was evaluated with Cervical Range of Motion (CROM) Device. Hierarchical Regression Analysis was conducted to examine the predictors of typing performance.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
21

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Afyonkarahisar, Turkey, 03030
        • Afyonkarahisar Health Sciences University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

22 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Office workers with neck pain, the sample of the study, were selected from among the people living in Istanbul with the invitation to volunteer.

Description

Inclusion Criteria:

  • Full-time and regular employees in the last 1 year,
  • Office employees use computers at desk for at least 3 hours per day
  • According to RULA, working in a posture that is above the acceptable level,
  • No trauma history
  • Non-specific neck pain but no chronic conditions of the cervical spine and upper extremity

Exclusion Criteria:

  • Volunteer office employees with neck pain who did not meet the inclusion criteria and those who could not complete the study because of pain, discomfort, etc. were excluded from the study (Dropouts; n=3 because of pain and discomfort, n=1 because of incomplete evaluations not completed on their own will)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort

Group / Cohort

A group or subgroup of participants in an observational study that is assessed for biomedical or health outcomes.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Office Employees Group
Office Employees with neck pain
Other: There will be no interventions.
Measurements and performance tests were conducted to investigate predictors of work-related performance

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Neck Disability Index (NDI)
Time Frame: 10 minutes
The NDI is a self-reported scale consists of pain intensity, personal care, lifting, reading, headache, concentration, work, driving, sleeping and leisure time activities sections. The total score varies between 0-50 and the increase in total score indicates the increase in the severity of the neck disability: "0-4 no disability, 5-14 mild disability, 15-24 moderate disability, 25-34 severe disability, and ≥35 complete disability".
10 minutes
Maximal Voluntary Isometric Contraction (MVIC)
Time Frame: 10 minutes
It is measured by Surface Electromyography (sEMG) for upper trapezius muscle. 3 maximum contractions were performed for 6 seconds at the manual muscle testing position. The maximum value among 3 repeats was recorded as Maximal Voluntary Isometric Contraction (MVIC) (mV).
10 minutes
Muscle Activation of Upper Trapezius
Time Frame: 30 minutes
It is the measurement of the Electromyographic activity of trapezius muscles during typing task. According to The Surface ElectroMyoGraphy for the Non-Invasive Assessment of Muscles Project (SENIAM) recommendations for sensors and sensor placement procedures, sEMG was applied for the upper trapezius muscles while performing the computer task in workplace. The mean values (mV) obtained were normalized according to MVIC. Normalized data (%MVIC) was used in the statistical analysis.
30 minutes
Forward Head Posture
Time Frame: 10 minutes
The CROM Deluxe is an assessment instrument that lets to measure sagittal, frontal and horizontal plane movements (flexion / extension, lateral flexion, rotation and forward head posture), while resting and also performing a task or work posture.
10 minutes
Rapid Upper Limb Assessment (RULA)
Time Frame: 10 minutes
The RULA Assessment Tool is used to evaluate the ergonomic risk factors associated with neck, trunk, and upper extremity musculoskeletal disorders (MSD). The RULA considers biomechanical and postural load requirements of job demands. Scores between 1-7 are classified from "acceptable posture" (no action required) to "very high risk" (implement change now).
10 minutes

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Body Mass Index (BMI)
Time Frame: 1 minutes
Body mass index (BMI) is a measurement derived from body mass and body height to evaluate body fat. The BMI is defined as the body mass divided by the square of the body height and is expressed in units of kg/m² (kilogram / square meter). According to the BMI value, it is categorized as underweight (<18.5), normal weight (18.5-24.9), overweight (25-29.9), and Obesity (30 or greater).
1 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Afyonkarahisar Health Sciences University

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Arzu Keskin Aktan, PhD, Afyonkarahisar Health Sciences University
  • Principal Investigator: Nilufer Keskin Dilbay, MSc, Marmara University
  • Study Director: Zafer Erden, PhD, Prof, Hacettepe University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
September 20, 2021

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
December 22, 2021

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
February 11, 2022

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
March 29, 2022

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
April 6, 2022

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
April 7, 2022

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
April 7, 2022

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
April 6, 2022

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
April 1, 2022

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 2018.282

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

There is no plan to make IPD available.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings